HR Positive, HER2 Negative Advanced Breast Cancer With Progression After Endocrine Therapy
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Solid Tumor, Adult
Interventions: BIOLOGICAL: EOC202|DRUG: albumin-bound paclitaxel
Sponsor: Taizhou EOC Pharma Co., Ltd.